Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Diago-Navarro

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Vaccines|October 27, 2022
Effectiveness of COVID-19 Vaccination Mandates and Incentives in EuropeLidia Kuznetsova, Elizabeth Diago-Navarro, Rachel Mathu, et al.
Msphere|March 4, 2021
Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected PatientsKasturi Banerjee, Michael P Motley, Elizabeth Diago-Navarro, et al.
Mbio|September 9, 2020
The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniaeMichael P Motley, Elizabeth Diago-Navarro, Kasturi Banerjee, et al.
Infection and Immunity|September 19, 2023
Inactivation of the Sts enzymes promotes resistance to lethal <i>Staphylococcus aureus</i> infectionAnika Zaman, Elizabeth Diago Navarro, Bettina C Fries, et al.
Molecular Microbiology|November 21, 2008
Novel Escherichia coli RF1 mutants with decreased translation termination activity and increased sensitivity to the cytotoxic effect of the bacterial toxins Kid and RelEElizabeth Diago-Navarro, Liliana Mora, Richard H Buckingham, et al.
Plasmid|January 17, 2012
Kis antitoxin couples plasmid R1 replication and parD (kis,kid) maintenance modulesJuan López-Villarejo, Elizabeth Diago-Navarro, Ana María Hernández-Arriaga, et al.
Plasmid|February 20, 2013
Cleavage of the antitoxin of the parD toxin-antitoxin system is determined by the ClpAP protease and is modulated by the relative ratio of the toxin and the antitoxinElizabeth Diago-Navarro, Ana María Hernández-Arriaga, Slawomir Kubik, et al.
The Lancet Regional Health. Europe|June 22, 2026
From Ebola to Hantavirus: Spain's Preparedness for High-Consequence Infectious DiseasesElizabeth Diago-Navarro, Claudia García-Vaz, Gonzalo Fanjul, et al.
Plos One|November 21, 2019
CRISPR-Cas influences the acquisition of antibiotic resistance in Klebsiella pneumoniaeNatalie A Mackow, Juntao Shen, Mutayyaba Adnan, et al.
Open Forum Infectious Diseases|June 19, 2023
Understanding the Relationship Between Antiviral Prescription Data and COVID-19 Incidence in New York City: A Retrospective Cohort StudyChristina M Kaul, Gabriel M Cohen, Matthew Silverstein, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Vaccines|October 27, 2022
Effectiveness of COVID-19 Vaccination Mandates and Incentives in EuropeLidia Kuznetsova, Elizabeth Diago-Navarro, Rachel Mathu, et al.
Msphere|March 4, 2021
Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected PatientsKasturi Banerjee, Michael P Motley, Elizabeth Diago-Navarro, et al.
Mbio|September 9, 2020
The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniaeMichael P Motley, Elizabeth Diago-Navarro, Kasturi Banerjee, et al.
Infection and Immunity|September 19, 2023
Inactivation of the Sts enzymes promotes resistance to lethal <i>Staphylococcus aureus</i> infectionAnika Zaman, Elizabeth Diago Navarro, Bettina C Fries, et al.
Molecular Microbiology|November 21, 2008
Novel Escherichia coli RF1 mutants with decreased translation termination activity and increased sensitivity to the cytotoxic effect of the bacterial toxins Kid and RelEElizabeth Diago-Navarro, Liliana Mora, Richard H Buckingham, et al.
Plasmid|January 17, 2012
Kis antitoxin couples plasmid R1 replication and parD (kis,kid) maintenance modulesJuan López-Villarejo, Elizabeth Diago-Navarro, Ana María Hernández-Arriaga, et al.
Plasmid|February 20, 2013
Cleavage of the antitoxin of the parD toxin-antitoxin system is determined by the ClpAP protease and is modulated by the relative ratio of the toxin and the antitoxinElizabeth Diago-Navarro, Ana María Hernández-Arriaga, Slawomir Kubik, et al.
The Lancet Regional Health. Europe|June 22, 2026
From Ebola to Hantavirus: Spain's Preparedness for High-Consequence Infectious DiseasesElizabeth Diago-Navarro, Claudia García-Vaz, Gonzalo Fanjul, et al.
Plos One|November 21, 2019
CRISPR-Cas influences the acquisition of antibiotic resistance in Klebsiella pneumoniaeNatalie A Mackow, Juntao Shen, Mutayyaba Adnan, et al.
Open Forum Infectious Diseases|June 19, 2023
Understanding the Relationship Between Antiviral Prescription Data and COVID-19 Incidence in New York City: A Retrospective Cohort StudyChristina M Kaul, Gabriel M Cohen, Matthew Silverstein, et al.
Pageof 3